Kevin Caliendo
Stock Analyst at UBS
(4.55)
# 244
Out of 5,156 analysts
207
Total ratings
72.82%
Success rate
12.38%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Buy | $10 → $5 | $3.04 | +64.47% | 4 | Feb 26, 2026 | |
| MDLN Medline | Maintains: Buy | $48 → $57 | $43.41 | +31.31% | 2 | Feb 26, 2026 | |
| LFST LifeStance Health Group | Maintains: Buy | $10 → $12 | $6.91 | +73.66% | 7 | Feb 26, 2026 | |
| HSIC Henry Schein | Maintains: Neutral | $79 → $87 | $78.10 | +11.40% | 7 | Feb 25, 2026 | |
| DGX Quest Diagnostics | Maintains: Neutral | $190 → $210 | $201.58 | +4.18% | 17 | Feb 11, 2026 | |
| ALGN Align Technology | Maintains: Neutral | $175 → $185 | $175.05 | +5.68% | 20 | Feb 5, 2026 | |
| XRAY DENTSPLY SIRONA | Maintains: Buy | $17 → $16 | $12.80 | +25.00% | 13 | Feb 3, 2026 | |
| NVST Envista Holdings | Maintains: Neutral | $22 → $25 | $26.70 | -6.37% | 5 | Feb 3, 2026 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $18 → $21 | $18.22 | +15.26% | 9 | Jan 14, 2026 | |
| CVS CVS Health | Maintains: Buy | $96 → $97 | $78.26 | +23.95% | 11 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $77 → $79 | $68.60 | +15.16% | 2 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $380 → $415 | $361.80 | +14.70% | 4 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.25 → $4 | $2.35 | +70.21% | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $920 → $980 | $942.16 | +4.02% | 17 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $220 | $222.28 | -1.03% | 18 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $378 → $430 | $285.17 | +50.79% | 13 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $320 | $273.61 | +16.95% | 7 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $146.03 | +16.41% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $5.56 | +61.87% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $269.66 | +44.63% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $178.53 | +40.03% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $43.32 | +82.36% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $280.74 | +104.82% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $242.59 | -25.80% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $5.30 | +1,258.49% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $31.50 | -65.08% | 4 | May 4, 2021 |
Evolent Health
Feb 26, 2026
Maintains: Buy
Price Target: $10 → $5
Current: $3.04
Upside: +64.47%
Medline
Feb 26, 2026
Maintains: Buy
Price Target: $48 → $57
Current: $43.41
Upside: +31.31%
LifeStance Health Group
Feb 26, 2026
Maintains: Buy
Price Target: $10 → $12
Current: $6.91
Upside: +73.66%
Henry Schein
Feb 25, 2026
Maintains: Neutral
Price Target: $79 → $87
Current: $78.10
Upside: +11.40%
Quest Diagnostics
Feb 11, 2026
Maintains: Neutral
Price Target: $190 → $210
Current: $201.58
Upside: +4.18%
Align Technology
Feb 5, 2026
Maintains: Neutral
Price Target: $175 → $185
Current: $175.05
Upside: +5.68%
DENTSPLY SIRONA
Feb 3, 2026
Maintains: Buy
Price Target: $17 → $16
Current: $12.80
Upside: +25.00%
Envista Holdings
Feb 3, 2026
Maintains: Neutral
Price Target: $22 → $25
Current: $26.70
Upside: -6.37%
Alignment Healthcare
Jan 14, 2026
Maintains: Neutral
Price Target: $18 → $21
Current: $18.22
Upside: +15.26%
CVS Health
Dec 10, 2025
Maintains: Buy
Price Target: $96 → $97
Current: $78.26
Upside: +23.95%
Nov 10, 2025
Maintains: Neutral
Price Target: $77 → $79
Current: $68.60
Upside: +15.16%
Nov 7, 2025
Maintains: Buy
Price Target: $380 → $415
Current: $361.80
Upside: +14.70%
Nov 6, 2025
Maintains: Neutral
Price Target: $4.25 → $4
Current: $2.35
Upside: +70.21%
Nov 6, 2025
Maintains: Buy
Price Target: $920 → $980
Current: $942.16
Upside: +4.02%
Oct 31, 2025
Maintains: Buy
Price Target: $185 → $220
Current: $222.28
Upside: -1.03%
Oct 29, 2025
Maintains: Buy
Price Target: $378 → $430
Current: $285.17
Upside: +50.79%
Oct 29, 2025
Maintains: Buy
Price Target: $325 → $320
Current: $273.61
Upside: +16.95%
Oct 24, 2025
Maintains: Neutral
Price Target: $180 → $170
Current: $146.03
Upside: +16.41%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $5.56
Upside: +61.87%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $269.66
Upside: +44.63%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $178.53
Upside: +40.03%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $43.32
Upside: +82.36%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $280.74
Upside: +104.82%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $242.59
Upside: -25.80%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $5.30
Upside: +1,258.49%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $31.50
Upside: -65.08%